Imperial College London
Portrait Picture

Simon Erridge

Faculty of Medicine, Department of Surgery & Cancer

Research Postgraduate
 
 
 
//

Contact

 

simon.erridge12

 
 
//

Location

 

Block B Hammersmith HospitalHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Erridge:2022:10.12968/bjnn.2022.18.Sup3.S28,
author = {Erridge, S and Sodergren, M and Weatherall, M},
doi = {10.12968/bjnn.2022.18.Sup3.S28},
journal = {British Journal of Neuroscience Nursing},
pages = {S28--S31},
title = {Medical cannabis in multiple sclerosis},
url = {http://dx.doi.org/10.12968/bjnn.2022.18.Sup3.S28},
volume = {18},
year = {2022}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating and neurodegenerative disease of the central nervous system that affects over 100 000 individuals in the UK. The symptoms of MS are heterogenous and correspond to the location of demyelination. However, common symptoms include sensory, motor, cognitive and affective disturbances. While the cornerstone of medical therapy is disease modifying agents, there is an ongoing need to develop symptomatic treatments. Cannabis-based medicinal products (CBMPs), which were partially legalised in the UK in November 2018, have been touted as a potential management option for the associated sequelae of MS. Nabiximols, an oromucosal spray containing cannabidiol and (−)-trans-Δ9-tetrahydrocannabinol, has been extensively evaluated for the treatment of MS-related spasticity. However, unlicensed CBMP formulations are a novel therapeutic class of medications, of which the clinical effects are less well known. Yet, there are promising indications for the use of CBMP in the symptomatic treatment of MS. This article reviews the literature on efficacy and safety of medical cannabis for people with MS.
AU  - Erridge,S
AU  - Sodergren,M
AU  - Weatherall,M
DO  - 10.12968/bjnn.2022.18.Sup3.S28
EP  - 31
PY  - 2022///
SN  - 1747-0307
SP  - 28
TI  - Medical cannabis in multiple sclerosis
T2  - British Journal of Neuroscience Nursing
UR  - http://dx.doi.org/10.12968/bjnn.2022.18.Sup3.S28
UR  - https://www.magonlinelibrary.com/doi/full/10.12968/bjnn.2022.18.Sup3.S28
UR  - http://hdl.handle.net/10044/1/105095
VL  - 18
ER  -
Download